Skip to main content
. 2022 Dec 15;247:115021. doi: 10.1016/j.ejmech.2022.115021

Table 2.

Antiviral and cytotoxicity evaluation of the most promising SARS-CoV-2 Mpro inhibitors.

Cmpd Huh-7-ACE2 cells infected EC50 (μM) Huh-7-ACE2 cells CC50 (μM) SI
SPR38 18.5 ± 6.5 60.9 ± 11.5 3
SPR39 1.5 ± 0.3 100 66.6
SPR41 1.8 ± 0.1 14.5 ± 3.4 8
Nirmatrelvir <0.01 >100 >10.000